Cookies

Like most websites The Pathologist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Subspecialties

Subspecialties Microbiology and immunology

Rapid Action Against MRSA

| Michael Schubert

Rapid, accessible, noninvasive technologies to detect MRSA could help diagnose patients and prevent transmission

Subspecialties Neurology

By the Numbers: Epilepsy and Neurodevelopmental Disorders

| Michael Schubert

Breaking down epilepsy and other neurodevelopmental disorders – the causes, the genetics, and those involved with diagnosis

Subspecialties Neurology

Predicting Prognosis in Glioblastoma

| Luke Turner

A link between cfDNA concentration and progression-free survival in glioblastoma patients supports the use of liquid biopsy when predicting prognosis

Subspecialties Microbiology and immunology

TB Triage

| Luke Turner

A blood-based triage test for TB could provide a cheap and reliable point-of-care diagnostic for people in low-resource areas

Subspecialties Microbiology and immunology

Non-Tuberculous Mycobacteria

| Michael Schubert

Reports on NTM lung disease – the risks, the symptoms, and the patient data

Subspecialties Histology

Molecular Drivers of Mesothelioma

| Stefania Erra, Carolina Pelazza

A case series that explores the potential molecular contributors to pleural mesothelioma carcinogenesis – and its treatment options

Subspecialties Oncology

Beating the Biopsy

| Michael Schubert

A new approach to prostate cancer testing aims to decrease unnecessary biopsies and reduce over-treatment

Subspecialties Microbiology and immunology

A Whole New (Microbial) World

| Luke Turner

New research uncovers thousands of previously unidentified tiny proteins in the microbiome that could advance our understanding of human health

Subspecialties Cytology

A Better Future for Bladder Cancer

| John Cucci

A new immunocytochemistry stain offers a sensitive, noninvasive, and cost-effective diagnostic tool for patients at risk of bladder cancer

Subspecialties Cytology

Protecting Patients from Progression

| Michael Schubert

A new molecular test offers the first opportunity to identify the patients who are most likely to benefit from treatment, rather than surveillance

Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine

Register